We compared the distributions of splicing program activity differences based on whether the tumors harbored mutations in splicing factors, and more specifically, whether those mutations occurred in splicing factors that are part of the oncogenic-like or tumor suppressor-like programs. Here, SLU7 is linked to neoplasm.